|
TUBGCP3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.871700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.041700E-04 |
| Normal-vs-Stage2 |
3.870000E-01 |
| Normal-vs-Stage3 |
6.663000E-01 |
| Normal-vs-Stage4 |
9.754400E-02 |
| Stage1-vs-Stage2 |
2.595200E-01 |
| Stage1-vs-Stage3 |
1.516820E-03 |
| Stage1-vs-Stage4 |
1.73672999999042E-05 |
| Stage2-vs-Stage3 |
2.594800E-01 |
| Stage2-vs-Stage4 |
6.600300E-02 |
| Stage3-vs-Stage4 |
2.967000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.116580E-01 |
| Normal-vs-AfricanAmerican |
4.689800E-01 |
| Normal-vs-Asian |
1.811430E-01 |
| Caucasian-vs-AfricanAmerican |
9.502400E-01 |
| Caucasian-vs-Asian |
2.036200E-01 |
| AfricanAmerican-vs-Asian |
2.544000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.244800E-01 |
| Normal-vs-Female |
4.841800E-03 |
| Male-vs-Female |
1.240350E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.220200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.110400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.839800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.368400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.766400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.209000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.896200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.129200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.268960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.916800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.544560E-03 |
| Normal-vs-Grade 2 |
1.363010E-04 |
| Normal-vs-Grade 3 |
9.374400E-01 |
| Normal-vs-Grade 4 |
1.116300E-02 |
| Grade 1-vs-Grade 2 |
3.789500E-02 |
| Grade 1-vs-Grade 3 |
1.968040E-04 |
| Grade 1-vs-Grade 4 |
2.28759999998385E-06 |
| Grade 2-vs-Grade 3 |
2.158400E-04 |
| Grade 2-vs-Grade 4 |
6.19930000000934E-07 |
| Grade 3-vs-Grade 4 |
1.043700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.14829999953159E-08 |
| Normal-vs-ccB subtype |
7.935500E-02 |
| ccA subtype-vs-ccB subtype |
3.74922315415915E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.965600E-01 |
| Normal-vs-N1 |
4.103600E-01 |
| N0-vs-N1 |
2.661000E-01 |
|
|
